Dose Level 3
Sponsors
Baylor College of Medicine, Pfizer, Brown University, Jichi Medical University, Institute of Cancer Research, United Kingdom
Conditions
High Grade Serous Ovarian CancerKidney CancerLeukemiaLymphomaMetastatic Pancreatic CancerMyelomaRelapsed or Refractory B-Cell Non-Hodgkin LymphomaRheumatoid Arthritis
Phase 1
Treating High Risk Leukemia With CD40 Ligand & IL-2 Gene Modified Tumor Vaccine
CompletedNCT00058799
Start: 1999-06-30End: 2010-06-30Updated: 2020-01-21
Phase I Study Of The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of PF-04236921 In Patients With Rheumatoid Arthritis
CompletedNCT00838565
Start: 2009-05-20End: 2012-02-02Updated: 2018-11-02
BrUOG 278: FOLFOX-A For Pancreatic Cancer A Brown University Oncology Research Group Study
CompletedNCT01744353
Start: 2012-11-30End: 2015-08-31Updated: 2020-02-17
Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes
NCT02134262
Start: 2014-05-31End: 2017-03-31Target: 18Updated: 2014-11-06
Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer
RecruitingNCT06976892
Start: 2025-08-31End: 2029-12-31Target: 33Updated: 2025-08-13
CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors
Not yet recruitingNCT07297160
Start: 2026-06-01End: 2044-12-01Target: 88Updated: 2026-03-04